HR+/HER2- breast cancer involves cells that test positive for hormone receptors and negative for HER2 proteins. It's the most ...

Typically, triple-negative and HER2-positive breast cancers are much ... If breast cancer is coming back systemically (distantly), symptoms can vary based on where the cancer has returned.

Please provide your email address to receive an email when new articles are posted on . San Antonio Breast Cancer Symposium 2024 provided multiple updates in the field of HER2-positive breast ...

Dr. Debu Tripathy breaks down the FDA approval of Enhertu in unresectable or metastatic HR-positive, HER2-low or -ultralow ...

When breast cancer spreads to other parts of the body, it’s called metastatic breast cancer. Knowing the common places where ...

At the age of just 30, and excited about starting life with her partner, Niamh Noonan was stunned when she was diagnosed with triple positive breast cancer – and is now passionate about raising ...

Paolo Tarantino, MD, PhD, discusses elacestrant as a treatment option for patients with ESR1-mutated metastatic breast cancer in the second line.

Share on Facebook. Opens in a new tab or window Share on Bluesky. Opens in a new tab or window Share on X. Opens in a new tab or window Share on LinkedIn. Opens in a new tab or window A fourth of ...